{"organizations": [], "uuid": "ef8a6571b3723292c4700f64d5ad1c33041012ca", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180409.html", "section_title": "Archive News &amp; Video for Monday, 09 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-us-fda-says-issued-order-to-restri/brief-u-s-fda-says-issued-order-to-restrict-sale-distribution-of-bayers-essure-device-idUSFWN1RM0Q2", "country": "US", "domain_rank": 408, "title": "BRIEF-U.S. FDA Says Issued Order To Restrict Sale & Distribution Of Bayer's Essure Device", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.996, "site_type": "news", "published": "2018-04-10T00:15:00.000+03:00", "replies_count": 0, "uuid": "ef8a6571b3723292c4700f64d5ad1c33041012ca"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-us-fda-says-issued-order-to-restri/brief-u-s-fda-says-issued-order-to-restrict-sale-distribution-of-bayers-essure-device-idUSFWN1RM0Q2", "ord_in_thread": 0, "title": "BRIEF-U.S. FDA Says Issued Order To Restrict Sale & Distribution Of Bayer's Essure Device", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "u.s. food and drug administration", "sentiment": "negative"}, {"name": "bayer", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 9 (Reuters) - U.S. Food And Drug Administration:\n* U.S. FOOD AND DRUG ADMINISTRATION SAYS ISSUED AN ORDER TO RESTRICT THE SALE AND DISTRIBUTION OF BAYERâ€™S ESSURE DEVICE\n* NEW ESSURE LABELING RESTRICTS SALE TO HEALTH CARE PROVIDERS, FACILITIES THAT PROVIDE INFORMATION TO PATIENTS ABOUT RISKS, BENEFITS OF DEVICE\n* DETERMINED THAT SOME WOMEN STILL ARE NOT RECEIVING INFORMATION ABOUT THE KNOWN RISKS OF ESSURE BEFORE IMPLANTATION Source text: ( bit.ly/2IGL9Fr ) Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://bit.ly/2IGL9Fr", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://www.linkedin.com/company/10256858/", "https://instagram.com/reuters/"], "published": "2018-04-10T00:15:00.000+03:00", "crawled": "2018-04-10T12:41:52.003+03:00", "highlightTitle": ""}